Omega Sure

Omega Sure

Paradise4.7 (1,596 ratings)
Format:Softgel Quantity: 60 Softgel(s) · 60 servings
Goals
$22.63 $0.37 per serving

Product analysis

52 out of 100

Omega Sure provides EPA and DHA at a competitive combined cost, with limited support for effects on blood-fat and inflammation markers.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality21

The active fats are associated with a natural triglyceride oil, which has favorable absorption characteristics. Their individual forms are not separately identified, limiting a more detailed comparison.

Ingredient Transparency45

EPA and DHA amounts are clearly stated, but several other fat details are incomplete. Specific forms are mostly unspecified, and part of the oil composition remains uncertain.

Value For Money68

The combined EPA and DHA cost is favorable, with EPA offering the stronger individual value. DHA is more expensive relative to its amount.

Customer Satisfaction84

Customer satisfaction is high across a substantial review base. Ratings do not establish changes in blood fats, inflammation or skin health.

Product Focus69

EPA and DHA relate mainly to blood-fat and inflammation markers. The 400 mg EPA and 200 mg DHA serving does not match the much higher amounts used for blood-fat changes, and routine skin benefits remain uncertain.

Format
Softgel
Container
60 Softgel(s)
Per serving
$0.37
Customer rating
4.7 · 1,596 ratings
Report analysis

Goals

Cardiovascular Support
Impact
High effect
B- Ingredient FitC PathwaysB+ EvidenceA+ Formulation Logic
Fish Oil · 1000 mg

The separately declared EPA and DHA connect this product mainly to triglyceride metabolism. Its 400 mg EPA and 200 mg DHA per serving receive partial amount recognition; the supplied trials used much higher daily amounts, so equivalent triglyceride changes cannot be assumed. The oil carrier does not add a separate benefit, and these findings do not establish cardiovascular-event prevention.

How this product is rated for Cardiovascular Support

Ingredient fit73

Declared EPA and DHA provide the main cardiovascular connection.
Goal fit
Declared EPA and DHA provide the main cardiovascular connection.
Dose adequacy
Both active amounts provide partial exposure; total oil weight is not substituted for them.

Pathways60

Triglyceride metabolism is the main area represented by the saved findings. The findings are concentrated in one area, with limited wider cardiovascular coverage.
Depth
Triglyceride metabolism is the main area represented by the saved findings.
Breadth
The findings are concentrated in one area, with limited wider cardiovascular coverage.

Evidence83

EPA provides the strongest eligible evidence finding; its recognized amount does not establish cardiovascular-event prevention.
Evidence strength
EPA provides the strongest eligible evidence finding; its recognized amount does not establish cardiovascular-event prevention.
Studied preparation
The saved findings recognize studied preparations among the included ingredients; the preparation match does not extend the population or outcome evidence.

Formulation logic100

No listed conflict was triggered by the supplied ingredient facts. The included ingredients meet the saved minimum amount comparison.
Partner coverage
No required partner is missing among the recognized ingredients; this does not establish an extra benefit from combining them.
Conflicts
No listed conflict was triggered by the supplied ingredient facts.
Effective doses
The included ingredients meet the saved minimum amount comparison; this does not establish a proven clinical dose.
Study evidence
Fish Oil Supportive 185 studies
Inflammation
Impact
Moderate effect
C- Ingredient FitF PathwaysC+ EvidenceA+ Formulation Logic
Fish Oil · 1000 mg

EPA and DHA may lower blood markers of inflammation, including CRP and certain inflammatory signalling proteins. The serving declares 400 mg EPA and 200 mg DHA, rather than leaving their amounts hidden within a fish-oil total. Marker changes don't necessarily mean you'll notice less pain or other symptoms, and a reliable everyday anti-inflammatory benefit is unclear.

How this product is rated for Inflammation

Ingredient fit58

EPA (eicosapentaenoic acid) explain the main ingredient connection. Their relevance depends on the specific benefit and serving amount, rather than the number of other ingredients.
Goal fit
EPA (eicosapentaenoic acid) provide the relevant connection to inflammation; other declared ingredients do not necessarily add a separate benefit.
Dose adequacy
EPA (eicosapentaenoic acid) 400 mg per selected serving. These are comparisons with ingredient-specific amounts, not guarantees of inflammation relief.

Pathways8

The main connection concerns fatty-acid signalling. Biological pathways do not predict how much relief someone will experience.
Depth
The strongest ingredient connection concerns fatty-acid signalling; this describes a biological route rather than a predictable symptom benefit.
Breadth
The ingredient connections concern fatty-acid signalling, with limited breadth beyond those routes.

Evidence70

EPA (eicosapentaenoic acid) has relevant but qualified inflammation findings. Changes in blood markers should not be treated as reliable symptom relief.
Evidence strength
EPA (eicosapentaenoic acid) has relevant inflammation context, but blood-marker changes do not guarantee a noticeable everyday benefit.
Studied preparation
The relevant ingredient forms match the forms behind their inflammation context; that does not remove limits on who may benefit.

Formulation logic100

The relevant ingredients can act without a required partner, and no particular conflict is identified. Amount comparisons do not prove that combining ingredients adds benefit.
Partner coverage
The relevant ingredients do not require an additional partner ingredient for their individual connection to this goal.
Conflicts
No particular ingredient conflict is identified for this goal.
Effective doses
EPA (eicosapentaenoic acid) 400 mg per serving provide the relevant amount comparisons; a comparison alone does not prove effectiveness.
Study evidence
Fish Oil Supportive 68 studies
Skin Health
Impact
High effect
B+ Ingredient FitD- PathwaysB EvidenceA+ Formulation Logic
Omega-3 · 100 mg

The omega-3 fatty acids relate to skin lipids, but the supplied oral UV-challenge findings used a specific purified EPA preparation. That evidence cannot establish a skin benefit from this generic omega-3 or fish-oil serving. The recorded amount comparison does not resolve differences in composition, preparation or the meaning of laboratory UV outcomes for routine skin care.

How this product is rated for Skin Health

Ingredient fit84

The relevant active is the main focus of the supplied ingredient findings. The relevant amounts only partially match the recorded exposure comparison, with unresolved amounts contributing nothing to that comparison.
Goal fit
The relevant active is the main focus of the supplied ingredient findings.
Dose adequacy
The relevant amounts only partially match the recorded exposure comparison, with unresolved amounts contributing nothing to that comparison.

Pathways41

The strongest recorded connection concerns epidermal barrier lipids; this describes the ingredient connection, not a demonstrated cosmetic result.
Depth
The strongest recorded connection concerns epidermal barrier lipids; this describes the ingredient connection, not a demonstrated cosmetic result.
Breadth
The recorded connection is concentrated in epidermal barrier lipids, with limited coverage of other tracked skin functions.

Evidence78

Specific purified EPA has human UV-challenge data, but that does not establish a generic omega-3 skin effect.
Evidence strength
Specific purified EPA has human UV-challenge data, but that does not establish a generic omega-3 skin effect.
Studied preparation
The recorded preparation comparison is satisfied, but preparation-specific study findings do not automatically transfer to every ingredient or finished product.

Formulation logic100

No required partner was missing and no defined conflict was identified. The relevant amounts meet the recorded minimum comparison; this is not proof of a clinically effective skin dose.
Partner coverage
No required partner was missing in the recorded findings; this does not establish an added combination benefit.
Conflicts
No defined ingredient conflict was identified in the supplied findings.
Effective doses
The relevant amounts meet the recorded minimum comparison; this is not proof of a clinically effective skin dose.
Study evidence
Omega-3 Supportive 35 studies

Ingredients

IngredientAmount per servingScore
Calories
9 Calorie(s)
Calories from Fat
9 Calorie(s)
Total Fat
1 Gram(s)
Saturated Fat
0 Gram(s)
Trans Fat
0 Gram(s)
Omega-3 Fish Oil Concentrate (Anchovy, Mackerel, Sardine)
1000 mg 82
Omega-3 Fatty Acids
700 mg 86
Eicosapentaenoic Acid
400 mg 81
Docosahexaenoic Acid
200 mg 66
Other Omega-3 Fatty Acids
100 mg 86
Adults 18–50 Vegetarian
Report overview
Omega-3 · 700 mg OverallScore86
A+ Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyA+ Value
Each serving provides 400 mg EPA and 200 mg DHA. The oil is identified as a triglyceride form.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

The oil is identified as a triglyceride form. A protective ingredient is recorded, though freshness was not measured in these facts.
Molecular Form & Absorption Potential
The oil is identified as a triglyceride form.
Source Purity & Oxidative Protection
A qualifying oil source and an antioxidant are recorded; that does not establish measured freshness or oxidation.

Dose, Safety & Label Transparency64

The serving lists 400 mg EPA and 200 mg DHA separately. Together they account for about 60% of the oil.
EPA & DHA Label Specificity
The serving lists 400 mg EPA and 200 mg DHA separately.
Active Ingredient Concentration
EPA and DHA together account for about 60% of the listed oil mass.
Third-Party Purity Verification
A testing or distillation claim is recorded, but an available analysis certificate is not established in the saved facts.

Value100

The whole-product price works out to about $0.63 per gram of EPA and DHA combined.
Price per 1000mg of EPA+DHA
The whole-product price works out to about $0.63 per gram of EPA and DHA combined.
B+ Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyB+ Value
Each serving provides 400 mg of EPA in triglyceride form alongside 200 mg of DHA. The whole product costs about $0.94 per 1,000 mg of EPA.
How this ingredient is rated

Active Ingredient Quality & Bioavailability83

The oil is identified as triglycerides, and EPA makes up about 40% of the stated fish oil. Tocopherol is recorded.
Molecular Form and Bioavailability
The oil is identified as triglycerides, a form favored in the evaluation.
EPA Concentration Density
EPA makes up about 40% of the stated fish-oil amount per serving.
Oxidation Protection
Tocopherol is recorded as an antioxidant; its presence does not establish measured freshness.

Dose, Safety & Label Transparency80

Each serving provides 400 mg of EPA and 200 mg of DHA. A qualifying testing or certification claim is recorded.
Absolute EPA Dose per Serving
Each serving provides 400 mg of EPA, a mid-range amount in this comparison.
EPA-Centric Ratio
Each serving has 400 mg of EPA and 200 mg of DHA; EPA predominates.
Purity and Contaminant Testing
The saved evaluation records a contaminant-testing or certification claim; it does not independently verify the results.

Value80

The whole product costs about $0.94 per 1,000 mg of EPA, a relatively low cost in this evaluation.
Price per Gram of EPA
The whole-product price is about $0.94 per 1,000 mg of EPA; the evaluation considers that relatively low.
A- Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyB+ Value
Each serving provides 600 mg of EPA and DHA combined from 1,000 mg of fish oil. The saved facts identify the oil as triglyceride form.
How this ingredient is rated

Active Ingredient Quality & Bioavailability86

The saved facts identify the oil as triglyceride form. A specific purification method and third-party testing are recorded as claims.
Omega-3 Molecular Form
The saved facts identify the oil as triglyceride form.
Purification & Filtration Method
The saved assessment records a specific purification-method claim; that claim is not independent proof of contaminant removal.
Third-Party Purity & Potency Verification
The saved assessment records a third-party testing claim without identifying the program.
Source & Sustainability
The assessment recognizes a named fish source, but the species is not specified in the saved facts.

Dose, Safety & Label Transparency78

Each serving has 600 mg EPA and DHA, about 60% of the stated fish oil. The saved facts record a qualifying antioxidant.
Total Active Omega-3 Dose (EPA + DHA)
Each serving supplies 600 mg of EPA and DHA combined, a mid-range amount in this assessment.
Omega-3 Potency & Concentration
The 600 mg of EPA and DHA represent about 60% of the 1,000 mg fish oil per serving.
EPA & DHA Individual Disclosure
EPA and DHA are separately stated as 400 mg and 200 mg per serving, respectively.
Oxidation Protection (Stabilizers)
A qualifying antioxidant is recorded in the saved facts; its presence does not establish measured freshness.

Value80

The whole-product serving price corresponds to about $0.63 per gram of EPA and DHA, a moderate cost in this comparison.
Cost Per Gram of Active EPA + DHA
The whole-product serving price corresponds to about $0.63 per gram of EPA and DHA, a moderate cost in this comparison.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  2. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  3. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  4. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  5. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  6. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsInflammation forFish Oil
  7. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsInflammation forFish Oil
  8. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsInflammation forFish Oil
  9. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsInflammation forFish Oil
  10. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledInflammation forFish Oil
  11. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  12. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  13. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsSkin Health forOmega-3
  14. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  15. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3